Article Details

FDA Extends Review of Amylyx ALS Treatment - Neurology Live

Retrieved on: 2022-06-03 17:03:23

Tags for this article:

Click the tags to see associated articles and topics

FDA Extends Review of Amylyx ALS Treatment - Neurology Live. View article details on hiswai:

Excerpt

The agency pushed the PDUFA date back citing new data analyses that constitute a significant amendment to the NDA.

Article found on: www.neurologylive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up